Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
42,438,927
-
Share change
-
-1,568,676
-
Total reported value
-
$1,845,959,029
-
Put/Call ratio
-
108%
-
Price per share
-
$43.47
-
Number of holders
-
237
-
Value change
-
-$78,943,579
-
Number of buys
-
118
-
Number of sells
-
156
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2021
As of 31 Dec 2021,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,438,927 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, EARNEST PARTNERS LLC, JANUS HENDERSON GROUP PLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., D. E. Shaw & Co., Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
239
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.